and exclusion. These methods provide a 40-to 400-fold enrichment. More recent stem cell purification protocols involve immunobead subtraction of lineage-positive cells (Lin-)I3 followed by FACS sorting based on monoclonal antibody (MoAb) labeling of stem cell surface markers. The phenotype Thyl.lLO Lin-Sca-l+ (Ly6A/E) identifies a population containing PHSC and day 12 colony-forming unitspleen (CFU-S12).13-15 Although mice ofboth Ly6" and Ly6b haplotypes express Ly6A/E molecules on peripheral blood cells, only Ly6b mice express Ly6A/E on PHSC.I6at7 The combination of Thyl.1 and Ly6A/E is found in only one congenic strain of mice.13 The c-kit receptor, with its crossspecies distribution, has now become a principal marker for the isolation of stem cell^.'^-^^ Primitive bone marrow cells enriched by the procedures outlined above have been assayed for CFU-S,335-7,9-L4 marrow-repopulating ability (MRA),3v5 30-day radiopr~tection,~" and reconstitution of lethally irradiated m i~e .~,~-~~'~~'~~ Of these assays, reconstitution is the only true measure of PHSC activity. However, although this assay has been useful for functional studies involving small numbers of transplanted PHSC, interpretations are partially obscured by the need to coinject radioprotective cells and by radiation-induced effects on host microenvironment. In our model, the W / W recipient is histocompatible with the donor and does not require radiation before transplantation. Thus, we avoid the need to inject radioprotective cells.
In the present study, we combined and extended protocols for elutriation and anti-c-kit MoAb staining for flow cytometry to develop a universally applicable model for the enrichment of PHSC in a bone marrow subset containing few CFU-S and progenitors. The purified PHSC obtained using this protocol were assayed in vivo for their physiologic properties and in vitro for RNA expression of the flk-2 gene.
MATERIALS AND METHODS
Mice. Three to 4-week-old female C57BL/6J mice were used as donors. WBB6F1-+/+ mice were used as recipients in the CFU-S12 assay and WBB6Fl-W/W" (W/W") mice were used as recipients in For personal use only. on August 30, 2017. by guest www.bloodjournal.org From
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763 the PHSC assay. All mice were obtained from Jackson Laboratories (Bar Harbor, ME).
CCE. Cell fractions were collected as reported p r e v i~u s l y .~~~ Briefly, a single cell suspension of 2 to 4 X IO8 donor cells was introduced into the separation chamber of a JEdB elutriation system (Beckman Instruments, Palo Alto, CA) at a flow rate of 15 mL/min (FR15) with a rotor speed of 3,000 RPM (1,260g). Cells were collected in 200-mL aliquots at FR15 (discarded), FR25, FR30, FR35, and rotor-off (R/O).
MoAb staining and flow cytometry. Cells from FR25, FR30, and FR35 were incubated with a mixture of rat MoAb directed against the following murine hematopoietic cell lineage-specific surface markers: B lymphocytes (B220), T lymphocytes (CD4 and CDS), granulocytes (Gr-I), and myelomonocytic cells (Mac-1) (Purchased from Caltag Laboratories, San Francisco, CA). In some experiments, the antierythroid MoAb TER-1 I9 (a gift from Dr Tatsuo Kina, Kyoto University, Kyoto, Japan) was added to the MoAb cocktail. Antibody-labeled Lin' cells were removed using magnetic immunobeads (Advanced Magnetics, Cambridge, MA). This lineage-depletion procedure reduced the number of cells in each fraction by greater than 75%. The remaining Lin-cells were stained for flow cytometry with a biotin-conjugated anti-c-kit MoAb (Ack-4)19-21 and subsequently stained with streptavidin-phycoerythrin (SA-PE). The cells were sorted using an EPICS Elite cell sorter (Coulter, Hialeah, FL) at a rate of 2,000 cell+ into subsets with high (c-kitBR) and low (c-kitDULL) c-kit expression. Sorted cells were reanalyzed by FACS and dead cells were excluded by propidium iodide staining. This protocol provided average yields of approximately 2 X IO4, 1 X lo5, and 2 X IO5 c-kitBR cells from FR25, FR30, and FR35 Lin-, respectively, at a punty of 70% to 95%.
The MoAb AA4.1-FITC (a gift from Dr Saul J. Sharkis, Johns Hopkins Oncology Center, Baltimore, MD) was used alone or in combination with Ack-4/biotin/SA-PE to isolate AA4. I+, AA4. I-, c-kitPOS AA4.I-and c-kitNEG AA4.1' cells for PHSC analysis. In other experiments, anti-CD4 MoAb was omitted from the MoAb cocktail used for lineage subtraction and the Lin-cells were then stained with anti-CD4 MoAb-fluorescein isothiocyanate (FITC) and anti-c-kit MoAb and sorted for c-kitws CD4+ and c-kit-CD4-populations. These subsets were assayed for PHSC activity.
Rho was added at a volume of 0.1 mL (0.1 pg) per 1 X IO6 elutriated Lin-cells in 0.9 mL 5% fetal calf serum (FCS) at 37°C for 20 minutes. The cells were then rinsed twice in 5% FCS, resuspended, and incubated for a period of 8 to 10 hours at 37°C to permit Rho efflux to occur.24 The cells were then stained with Ack-4/Biotin/SA-PE for c-kit expression and sorted into c-kitBR RhoDULL and c-kitBR RhoBR subsets for functional analysis.
CFU-S,2 assay. The CFU-SI2 assay was performed by the method of Till and M c C~l l o c h .~~ WBB6F1-+/+ recipients were given 900 rad total body radiation using a 137Cs gamma irradiator (Atomic Energy of Canada, Ottawa). Within 1 to 4 hours, the mice were injected with purified bone marrow cells via the tail vein. On day 12 posttransplantation, the spleens were removed and fixed in Telleyesniczky's solution (70% ethanokacetic acid:formalin; 20:l:l) and the CFU-SI, colonies were counted.
Purified c-kitBR cells (as few as IOO), c-kitDULL cells (as many as 2.5 X IO4), and c-kit-cells (as many as 5 X lo5) were administered to W / W recipients as a single injection via the tail vein. At 1-to 4-week intervals posttransplantation, the peripheral red blood cells were monitored for increases in donor hemoglobin by cellulose acetate electrophoresis.26 After 4 months, DNA was extracted from the thymus and bone marrow for Southern analysis to assay for repopulation of nucleated erythroid, myeloid, and lymphoid cells. The C57BL/6J donors are homozyRhodamine 123 staining.
Long-term repopulation assay. gous for single hemoglobin (Hbbs/Hbbs, 10-kb EcoRI fragment), and the W / W recipients are heterozygous for single/diffuse hemoglobin (50% Hbb"/SO% Hbbd, 10-kb and 7-kb EcoRI fragments)." Bone marrow and thymus DNA was digested with EcoRI and probed with a 6 1 I-bp PstI/BamHI fragment from the second intervening sequence of the @" " ' gene. RNA was extracted from unfractionated, partially purified, and highly purified bone marrow populations using Vanadyl Ribonucleoside Complex (BRL Life Technologies, Gaithersburg, MD) as described. 28 To generate sufficient amounts of RNA and to control for variation from preparation to preparation, RNA extracted from two populations of Lin-c-kitDULL and Linc-kitBR cells was pooled for each assay. Five micrograms of total RNA from each population was treated with DNase I (Promega, Madison, WI) and divided into two aliquots. One aliquot was treated with reverse transcriptase using random oligonucleotides as described by the manufacturer (US Biochemicals, Cleveland, OH). The other aliquot was treated with the identical reagents, except that the reverse transcriptase was omitted. The equivalent of 1-pg samples from the two reverse-transcriptase reactions were added to similar polymerase chain reactions (PCRs) containing the &-microglobulin primers described previou~ly.~~ The amplification parameters were 94°C for 30 seconds, 50°C for l minute, and 72°C for 2 minutes for 25 cycles. Polyacrylamide gel electrophoresis was used to resolve the 141-bp flk-2-specific product and the 232-bp @,-microglobulin product. mRNA analysis.
RESULTS
Separation and enrichment of e-kit-expressing bone marrow stem cells. Donor bone marrow cells (2 to 4 x lo8)
were separated into small and larger cells by CCE at FR25, FR30, and FR35, respectively. Cells expressing lineage markers were removed by magnetic immunobead subtraction. The Lin-fractions were then stained with Ack-4, an anti-c-kit MoAb, and separated by FACS into c-kitPOS and c-kitNEG cells (Fig 1) . Background was set at 1% of isotype labeling and cells were defined as c-kitmS if they were at a fluorescence level greater than background. This c-kitPoS subset was subdivided into c-kitDULL and c-kitBR. The ckitBR cells showed a fluorescence signal fivefold to 10-fold greater than background. The average number of Linc-kitPOS cells ranged from 2.8% in FR25 to 18.2% in FR35, and the c-kitBR subset ranged from 0.1% in FR25 to 3.1% in FR3 5. The FR25 and FR30 Lin-c-kitBR and c-kitNEG cells were assayed for CFU-SI,, as were the FR35 Lin-c-kitBR, c-kitDULL, and c-kitmG cells (Table 1) . FR25 Lin-c-kitBR cells contained an average of 79 CFU-SI, (< 2.7% of all c-kitBR CFU-SI,) and none were found in the c-kitNEG subset. In FR30 Linand FR35 Lin-, many CFU-SI, were present in the c-kitBR population, while few or none were present among the c-kitNEG cells. FR35 Lin-c-kitDULL cells contained CFU-SI,, but at a greatly reduced number and frequency compared with FR35 Lin-c-kitBR. This distribution of CFU-SI, among c-kitmS cells in elutriated fractions is consistent with the distribution obtained earlier by Jones et a16 and ourselves' using elutnated marrow fractions not further enriched by flow cytometry.
Long-term repopulation studies using c-kit-enriched PHSC. Normal bone marrow PHSC have a competitive CFU-S,2 in e-kit-expressing bone marrow cells. Table I , we estimate the ratio of PHSC to CFU-SI2 to be approximately I : I , 1:3, and 1:4 in FR25, FR30, and FR35 Lin-c-kit" subsets, respectively.
Mice that converted to 100% donor hemoglobin after a transplant of 200 cells from FR25 or FR30 Lin-c-kit" subsets were assayed for lymphoid and myeloid repopulation by Southern analysis of the &globin genes (Fig 3) . The donor $,n* genes reside on IO-kb EcoRI fragments, while the compound heterozygous W/Wy recipient has 14-kb @minor (which does not hybridize well to our probe), IO-kb pi*, and 7-kb F bands. Thymus and bone marrow from repopulated micecontained 90% to 100% donor IO-kb band. The 1% to 10% Hbbd 7-kb band was attributed to recipient stromal cells. This degree of thymus repopulation was equivalent to that of circulating red blood cells, which suggests that transplanted stem cells for these two lineages have a competitive advantage in the W/W" recipient. The lower rate of bone marrow repopulation observed by Southern analysis may indicate a reduced rate of granulocyte repopulation as compared with lymphocytes and erythrocytes. Recipients of as many as 5 X IO5 Lin-c-kitNEG cells showed no evidence of repopulation in the lymphoid, myeloid, or erythroid lineages.
The FR25, FR30, and FR35 Lin-c-kitPoS populations were also analyzed for expression of AA4.1 and CD4 surface antigens (Table 2) . PHSC in FR25 were present in the Lin-AA4.1-subset, but were not found in AA4.1+ or Lin-AA4. I + subExpression of AA4.1 and CD4 on PHSC. (Table 1) .
sets, even when as many as 3 x lo5 cells were injected per recipient. In FR35 subsets, PHSC were present in cell populations that were AA4.1+, Lin-AA4.1+, and Lin-AA4.1-. This suggests that the PHSC in FR25 and FR35 have a different expression pattern for this marker. When these results were extended to include two-color sorting for c-kit and AA4.1, all 19 recipients of cells in the subset FR35 Linc-kitPoS AA4.1-converted to 100% Hbb', while zero of nine mice that received FR35 Lin-c-kitNEG AA4.1' cells were repopulated. We also analyzed expression of CD4 using anti-CD4 MoAb and anti-c-kit MoAb. Repopulation of recipient mice was observed only in c-kitPoS populations regardless of whether they expressed CD4. There were no CD4+ PHSC in the FR25 Lin-c-kitPoS subset, whereas there were CD4+ PHSC in FR30 Lin-c-kitws cells. These data indicate that neither anti-AA4.1 MoAb nor anti-CD4 MoAb can be used to further enrich the Lin-c-kitBR populations. Cells from FR25, FR30, and FR35 Lin-fractions were stained with anti-c-kit MoAb and Rho and sorted into c-kitBR RhoDULL and c-kitBR RhoBR populations. There were CFU-SI, in both Lin-c-kitBR RhoDULL and Lin-c-kitBR RhoBR populations, but they were concentrated in RhoBR populations (data not shown). The representative ratios of Rho-DULL to RhoBR cells in FR25, FR30, and FR35 Lin-c-kitBR populations were 2.5: I , 1.1: 1, and 1 :2.6, respectively (Fig 4) . This observation was predicted, since the number of CFU-S12 increased in the c-kitBR population from FR25 to FR35. An injection of 100 Lin-c-kitBR RhoDULL cells from FR25, FR30, and FR35 repopulated a total of five of nine mice ( Table 3 ). The FR35 Lin-c-kitBR RhoDULL cell population showed a fivefold enrichment of the PHSC activity over the FR35 Lin-c-kitBR cells (two of three v one of eight mice repopulated with 100 cells), presumably due to removal of RhoBR CFU-SI, and/or other progenitors from the original FR35 Lin-c-kitBR population. Five of six recipients of 1,000 Lin-c-kitBR RhoDULL cells from FR25, FR30, and FR35 were converted to 100% Hbb'. Only one of nine recipients of 100 Lin-c-kitBR RhoBR cells from FR25, FR30, and FR35 subsets were repopulated with Hbb', whereas 1,000 of these cells converted three of six recipients. These data indiEnrichment of PHSC on the basis of Rho eflux. (Table 2) . One hundred cells from FR25 Lin-c-kifBR RhoDULL or FR35 Lin-c-kirBR RhoDULL subsets repopulated the thymus in one of three and two of three recipients, respectively, whereas bone marrow was not converted in any of six recipients. Although there is no clear explanation for this observation, we may not have allowed sufficient time for myeloid conversion in this limiting dilution study. In contrast, 100 and 1,000 donor cells from the FR30 Linc-kitBR RhoDULL subset repopulated thymus and bone marrow in eight of nine W / W mice. The high dose of 1,000 cells from the FR30 Lin-c-kif BR RhoBR subset repopulated both thymus and marrow in all recipients. In contrast, cells from FR25 and FR35 Lin-c-kitBR RhoBR subsets repopulated the thymus in one of seven and bone marrow in one of 10 recipients.
Gene expression in purified populations. The flk 2 gene, a member of the tyrosine kinase receptor family, has been reported to be a marker for the most primitive fetal liver hematopoietic cells. 33 To test whether flk-2 expression might also be a marker for adult bone marrow PHSC, RNA was purified from several populations of bone marrow cells in various stages of purity (Fig 5) . Using reverse-transcrip tase PCR, we detected low levels of flk-2 mRNA in unfractionated bone marrow. Higher levels of flk-2 mRNA were seen in FR30, FR35, and R/O cells, in FR30 Lin-and FR35
For Lin-, and in FR35 Lin-c-kif-, c-kitDuu, and c -k P cells. In contrast, RNA isolated from cells in FR25 Linc-kif-and c-kifDUU contained low levels of flk-2 mRNA, and no flk-2 mRNA was detected in the FR25 Lin-c-kitBR subpopulation, a subpopulation enriched for PHSC activity and lacking CFU-SI,. The quantity of flk-2 mRNA in FR25 Lin-c-kifDUU cells was estimated by scanning densitometry at 12% of the B,-microglobulin mRNA level, whereas FR25 Lin-c-kirBR cells had no flk-2 mRNA while showing 35% of the &-microglobulin mRNA seen in FR25 Lin-c-kifDUU cells.
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DISCUSSION
The W locus encodes the c-kif proto-oncogene, a tyrosine kinase recepto?"' for SCEM3* Mice that are compound Table 3 . !hparatkn~ of PHSC on the Basis of c-kit E x p "
and Rho R e t e n t h Several studies describe MoAbs to c-kit that have been used to purify and mouselg21 progenitors and stem cells. Two of these MoAbs recognize different epitopes on the extracellular domain of the mouse c-kit receptor. One, Ack-2, blocks blood cell formation when administered in vivo. We used the MoAb, Ack-4, which is not antagonistic to hematopoiesis, to subdivide FR25, FR30, and FR35 Linbone marrow cells into c-kit'", c-kitDULL, and c-kirNEG subsets.
Using the W/wy model, we were able to repopulate the thymus and bone marrow of approximately 50% of recipients given 100 to 200 FR25 or FR30 Lin-c-kif'" cells. This represents a 500-to I ,000-fold enrichment of PHSC from a population of unfractionated bone marrow. Nonirradiated W / W mice, used in our study, did not require the coinjection of radioprotective cells to supplement the FR25, FR30, and FR35 Lin-c-kir-PHSC subsets.
The PHSC fractionation procedure used here enabled us to extend the observation of Okada et al?' who showed that 100 c-kifm cells from unfractionated, sorted marrow can reconstitute lethally irradiated mice provided the recipients were also coinjected with radioprotective cells. Furthermore, the c-kit* cells used by Okada et a12' may have included numerous CFU-S12 and other progenitors, whereas our FR25 Lin-c-kif'" cells contained PHSC with few or no contaminating CFU-S12 (one CFU-SI, per 253 FR25 Lin-c-kitBR cells, see Table 1 ) or progenitor cells.6
The c-kif Sca-I double-positive PHSC isolated by Okada et a12' were in the c -k P fraction as defined in our study.
Several other markers have been used to fractionate bone The AA4.1 antigen was initially used to identify pre-B cells in hematopoietic tissue.40 Subsequently, it was identified as a marker for myeloid-erythroid progenitors (CFU-GEMM), day 12 to 16 CFU-S, and long-term repopulating stem cells in a 0.5% to 1% subpopulation of fetal liver hematopoietic cells."' We observed an equivocal pattern of AA4.1 antigen expression on PHSC from mouse bone marrow. PHSC were present in all AA4.1-subsets tested and in some of the AA4.1' subsets. This observation represents a clear difference between PHSC in fetal liver, which are all AA4. I+, and adult bone marrow. in RNA from the FR35 subsets enriched for both CFU-SI, and PHSC (Lin-c-kitBR) or CFU-SI, alone (Lin-c-kitDULL), we were unable to detect flk-2 mRNA in RNA extracted from FR25 Lin-c-kitBR bone marrow cells that were highly enriched for PHSC but depleted of CFU-SI,. These data argue that flk-2 mRNA is not expressed in the fraction of PHSC present in the subset elutriated at FR25.' This may represent a fundamental difference between FR25 Lin-ckitBR PHSC and those from fetal liver. We suggest that AA4.1 and/or flk-2 are specific markers on PHSC in cell cycle. Fetal liver PHSC are AA4. I + and flk-2+ and are likely to be in a state of exponential cell growth. In contrast, many PHSC in adult bone marrow are expected to be in a resting Go phase. These may be the small PHSC in FR25 that are The protocol that we developed here has several advantages over previously reported models. First, we are able.to isolate a high expression c-kit subset that contains PHSC with relatively few contaminating CFU-Sl2 and other progenitors. Second, the W/Wv mice used by us do not require irradiation; thus, purified PHSC can be assayed free of coinjected radioprotective cells. Third, the W / W model provides an opportunity to trace the progeny of small numbers of PHSC (theoretically a single PHSC) for a 4-month interval during which the recipient lymphomyeloid tissues become 100% repopulated. Finally, our protocol can be used on all strains of mice for PHSC purification and provides an assay to study the biologic and functional characteristics of a single or relatively few transplanted PHSC.
